ArticleNPJ breast cancer2026
Flavonoid-rich foods, genetic risk, and female breast cancer risk: a prospective cohort study.
Article in NPJ breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The Flavodiet Score (FDS) represents flavonoid-rich food intake, but its association with breast cancer risk and whether genetic risk modifies this association remain unclear. We analyzed data from 93,271 females in the UK Biobank with a median follow-up of 11.8 years. Associations were examined using delayed-entry Cox proportional hazards regression models. The polygenic risk score (PRS) for breast cancer was constructed based on 168 single nucleotide polymorphisms. Results showed that females in the highest FDS quintile had a 15% reduced risk compared with those in the lowest quintile. Higher intakes of specific flavonoid subclasses (such as flavanones and proanthocyanidins) and of flavonoid-rich foods (including oranges and apples) were also associated with reduced breast cancer risk. Furthermore, the association between FDS and breast cancer risk did not vary significantly according to menopausal status. Notably, among females with high PRS, those in the highest quintile of FDS showed a significantly reduced breast cancer risk. In conclusion, adherence to a flavonoid-rich diet may reduce breast cancer risk, providing valuable guidance for future intervention studies and public health strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.